资本眼一周行情 上周（6月22日至28日），医药生物指数终于止跌，上涨0.07%，跑赢上证指数1.62个百分点。创新药（BK1106）周内下跌2.45%；恒生医疗保健业指数（HSCICH）周内下跌1.06%；港股创新药ETF广发（513120）周内上涨1.71%。 机构观点 开源证券 本月创新药研发及商业化进展保持活跃，多款创新药取得关键节点突破。百利天恒BL-B01D1、科济药业...
Source Link资本眼一周行情 上周（6月22日至28日），医药生物指数终于止跌，上涨0.07%，跑赢上证指数1.62个百分点。创新药（BK1106）周内下跌2.45%；恒生医疗保健业指数（HSCICH）周内下跌1.06%；港股创新药ETF广发（513120）周内上涨1.71%。 机构观点 开源证券 本月创新药研发及商业化进展保持活跃，多款创新药取得关键节点突破。百利天恒BL-B01D1、科济药业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.